These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 33276251

  • 1. A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study.
    Kupczyk M, Majak P, Kuna P, Asankowicz-Bargiel B, Barańska E, Dobek R, Garbicz S, Jerzyńska J, Latos A, Machowiak W, Majorek-Olechowska B, Olech-Cudzik A, Poziomkowska-Gęsicka I, Rulewicz-Warniełło M, Świderska A, Tarnowski M, Kopyto P.
    Respir Med; 2021 Jan; 176():106274. PubMed ID: 33276251
    [Abstract] [Full Text] [Related]

  • 2. A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.
    Mansfield L, Yiu G, Sakov A, Liu S, Caracta C.
    Allergy Asthma Proc; 2017 Jul 24; 38(4):264-276. PubMed ID: 28540844
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan 24; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 4. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
    Sher LD, Yiu G, Sakov A, Liu S, Caracta CF.
    Allergy Asthma Proc; 2017 Sep 21; 38(5):343-353. PubMed ID: 28639542
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L, Humphries M, Du X, Wang L, Jiang J.
    Int J Clin Pract; 2005 Jul 21; 59(7):754-9. PubMed ID: 15963199
    [Abstract] [Full Text] [Related]

  • 6. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
    Bateman ED, Silins V, Bogolubov M.
    Respir Med; 2001 Feb 21; 95(2):136-46. PubMed ID: 11217910
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
    Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
    Ann Allergy Asthma Immunol; 2003 Sep 21; 91(3):263-9. PubMed ID: 14533658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ, Currie GP, Lipworth BJ.
    J Allergy Clin Immunol; 2002 Jun 21; 109(6):929-35. PubMed ID: 12063520
    [Abstract] [Full Text] [Related]

  • 11. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov 21; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 12. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma.
    Nugent C, Yiu G, Song S, Caracta C.
    J Asthma; 2018 Aug 21; 55(8):898-906. PubMed ID: 28933971
    [Abstract] [Full Text] [Related]

  • 13. An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma.
    Usmani O, Roche N, Marshall J, Danagher H, Price D.
    Expert Opin Drug Deliv; 2019 Dec 21; 16(12):1367-1380. PubMed ID: 31752560
    [Abstract] [Full Text] [Related]

  • 14. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar 21; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
    J Allergy Clin Immunol; 2008 Jun 21; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 21; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler.
    Hojo M, Shirai T, Hirashima J, Iikura M, Sugiyama H.
    Pulm Pharmacol Ther; 2016 Apr 21; 37():43-8. PubMed ID: 26898348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.